Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel nimesulide sustained-release pharmaceutical composition and preparation method thereof

A composition and drug technology, applied in the sustained-release pharmaceutical composition of nimesulide and its preparation field, can solve the requirements of layer and layer cross-contamination yield, double-layer compression technology prescription and production process, and industrial production requirements Higher problems, to achieve the effects of fast drug onset, good patient compliance, and good bioavailability

Active Publication Date: 2015-04-29
INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As we all know, the prescription and production process of double-layer tablet technology are relatively complicated, and the requirements for industrial production are high. Problems such as tablet weight difference control, cross-contamination between layers, and low yield in the production process have become constraints for double-layer tablet technology. major factors of development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel nimesulide sustained-release pharmaceutical composition and preparation method thereof
  • Novel nimesulide sustained-release pharmaceutical composition and preparation method thereof
  • Novel nimesulide sustained-release pharmaceutical composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1: Nimesulide tablet containing alkalizing agent is prepared by direct compression method

[0048] Table 1: Prescription

[0049]

[0050] Among them, the alkalizing agent is magnesium hydroxide, magnesium silicate, sodium carbonate, sodium bicarbonate, calcium hydrogen phosphate, magnesium oxide, magnesium hydroxide, sodium citrate, trishydroxymethylaminomethane, meglumine, and acrylic resin.

[0051] Preparation:

[0052] Weigh the raw and auxiliary materials according to the prescription amount in Table 1, pass through an 80-mesh sieve, mix evenly, and tablet.

[0053] According to the prescription quantity of prescription 1-4 in table 1, apply above-mentioned method to prepare alkalizing agent respectively and be magnesium hydroxide, magnesium silicate, sodium carbonate, sodium bicarbonate, calcium hydrogen phosphate, magnesium oxide, magnesium hydroxide, citric acid Sodium, Tris, Meglumine, Acrylic Tablets.

[0054] One skilled in the art would als...

Embodiment 2

[0055] Embodiment 2: Nimesulide tablet or capsule containing alkalizing agent prepared by wet granulation process

[0056] Preparation:

[0057] Weigh nimesulide, alkalinizing agent sodium bicarbonate, and other solid preparation molding auxiliary materials hypromellose, lactose, and micropowder silica gel according to the prescription amount of prescription 3 in Table 1, and mix them through an 80-mesh sieve; Measure a non-aqueous solvent as a wetting agent (ethanol), make the above-mentioned mixture into a soft material, pass through a 20-mesh sieve to make wet granules, and dry the wet granules at 60°C to obtain dry granules. A certain amount of lubricant magnesium stearate is added to the dry granules, passed through a 16-mesh sieve, mixed, granulated, compressed into tablets whose main ingredient is nimesulide, or directly filled into capsules to prepare capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a novel nimesulide sustained-release pharmaceutical composition and a preparation method thereof. The novel nimesulide sustained-release pharmaceutical composition contains nimesulide as an active component, an alkalizer and any pharmaceutically acceptable auxiliary materials. The novel nimesulide sustained-release pharmaceutical composition has the advantages of simple formula, easy operation, stable quality, strong controllability and good reappearance.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a pharmaceutical composition and a preparation method thereof, in particular to a sustained-release pharmaceutical composition of nimesulide and a preparation method thereof. Background technique [0002] Nimesulide (N-(4-nitro-2-phenoxybenzene) methanesulfonamide, formula 1) is a new type of non-steroidal anti-inflammatory drug developed by Boehringer Mannheim in West Germany, which was launched in Italy in 1985 , is the first selective cyclooxygenase (Cyclooxygenase, COX) inhibitor. Nimesulide has strong inhibitory activity on inflammation-related COX-2, but weak inhibitory activity on COX-1, thus showing highly selective anti-inflammatory activity and antipyretic and analgesic effects, as well as lower gastrointestinal Road and kidney side effects. Therefore, nimesulide has the characteristics of high efficiency and low toxicity, and is superior to othe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/18A61K47/04A61K47/12A61K47/18A61K47/32A61P29/00A61P19/02A61P15/00A61P11/00
Inventor 杨美燕高春生单利范云周王玉丽白雪茜靳海明
Owner INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A